SSamsung Biologics Read More Samsung Biologics to Sustain Growth on Rockville, Plant 5July 24, 2026 Samsung Biologics’ Plant 4. Photo courtesy of Samsung Biologics Samsung Biologics (207940.KS) is expected to sustain its growth…
SSamsung Biologics Read More Samsung Biologics launches 1.46 billion CHF cash offer for PolyPeptide | Ukraine newsJuly 20, 2026 The proposed cash offer values PolyPeptide at 44.31 CHF per share and signals Samsung’s push to scale up…